Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1993 Dec;48(12):1222–1226. doi: 10.1136/thx.48.12.1222

Relation of HIV-I in bronchoalveolar lavage cells to abnormalities of lung function and to the presence of Pneumocystis pneumonia in HIV-I seropositive patients.

J R Clarke 1, I K Taylor 1, J Fleming 1, J D Williamson 1, D M Mitchell 1
PMCID: PMC464975  PMID: 8303627

Abstract

BACKGROUND--HIV is present in bronchoalveolar lavage cells of some but not all HIV seropositive patients. Abnormalities of lung function have been described in such patients in the absence of clinically overt pneumonia or other respiratory infections. It is possible that the presence of HIV in alveolar macrophages could account for these abnormalities. It is also possible that the presence of HIV in alveolar macrophages contributes to immunosuppression and an increased incidence of opportunistic infections. METHODS--This was a prospective study of 157 HIV seropositive patients requiring diagnostic bronchoscopy for investigation of new respiratory symptoms, chest radiograph abnormality, or pneumonic illness. Presence of HIV in bronchoalveolar lavage cells obtained at diagnostic bronchoscopy was determined by polymerase chain reaction to detect proviral DNA and in vitro cocultivation to detect productive virus infection. With these two techniques the presence or absence of HIV in bronchoalveolar lavage was compared with the presence of abnormalities of lung function or presence of Pneumocystis pneumonia. RESULTS--HIV was detected in bronchoalveolar lavage cells in 65% of patients by means of the polymerase chain reaction and 59% with cocultivation. With both methods of detection there was no association between the presence or absence of HIV and the presence of Pneumocystis pneumonia; nor was there a relation between the presence of HIV and abnormalities of lung function. CONCLUSION--The presence of HIV in bronchoalveolar lavage cells does not predispose to an increased incidence of Pneumocystis pneumonia; nor does it contribute to abnormalities of lung function.

Full text

PDF
1222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Autran B., Mayaud C. M., Raphael M., Plata F., Denis M., Bourguin A., Guillon J. M., Debre P., Akoun G. Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients. AIDS. 1988 Jun;2(3):179–183. [PubMed] [Google Scholar]
  2. Clarke J. R., Fleming J., Donegan K., Moss F. M., Nieman R., Williamson J. D., Mitchell D. M. Effect of HIV-1 and cytomegalovirus in bronchoalveolar lavage cells on the transfer factor for lung carbon monoxide in AIDS patients. AIDS. 1991 Nov;5(11):1333–1338. doi: 10.1097/00002030-199111000-00008. [DOI] [PubMed] [Google Scholar]
  3. Clarke J. R., Krishnan V., Bennett J., Mitchell D., Jeffries D. J. Detection of HIV-1 in human lung macrophages using the polymerase chain reaction. AIDS. 1990 Nov;4(11):1133–1136. doi: 10.1097/00002030-199011000-00012. [DOI] [PubMed] [Google Scholar]
  4. Clarke J. R., Taylor I. K., Fleming J., Nukuna A., Williamson J. D., Mitchell D. M. The epidemiology of HIV-1 infection of the lung in AIDS patients. AIDS. 1993 Apr;7(4):555–560. doi: 10.1097/00002030-199304000-00015. [DOI] [PubMed] [Google Scholar]
  5. Clarke J. R., Williamson J. D., Mitchell D. M. Comparative study of the isolation of human immunodeficiency virus from the lung and peripheral blood of AIDS patients. J Med Virol. 1993 Mar;39(3):196–199. doi: 10.1002/jmv.1890390304. [DOI] [PubMed] [Google Scholar]
  6. Dean N. C., Golden J. A., Evans L. A., Warnock M. L., Addison T. E., Hopewell P. C., Levy J. A. Human immunodeficiency virus recovery from bronchoalveolar lavage fluid in patients with AIDS. Chest. 1988 Jun;93(6):1176–1179. doi: 10.1378/chest.93.6.1176. [DOI] [PubMed] [Google Scholar]
  7. French P. D., Cunningham D. A., Fleming J., Donegan C., Harris J. R., Shaw R. J., Mitchell D. M. Low carbon monoxide transfer factor (TLCO) in HIV-infected patients without lung disease. Respir Med. 1992 May;86(3):253–256. doi: 10.1016/s0954-6111(06)80064-8. [DOI] [PubMed] [Google Scholar]
  8. Itescu S., Brancato L. J., Buxbaum J., Gregersen P. K., Rizk C. C., Croxson T. S., Solomon G. E., Winchester R. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med. 1990 Jan 1;112(1):3–10. doi: 10.7326/0003-4819-112-1-3. [DOI] [PubMed] [Google Scholar]
  9. Mitchell D. M., Fleming J., Pinching A. J., Harris J. R., Moss F. M., Veale D., Shaw R. J. Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients. Am Rev Respir Dis. 1992 Sep;146(3):745–751. doi: 10.1164/ajrccm/146.3.745. [DOI] [PubMed] [Google Scholar]
  10. Murray J. F., Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part I. Am Rev Respir Dis. 1990 May;141(5 Pt 1):1356–1372. doi: 10.1164/ajrccm/141.5_Pt_1.1356. [DOI] [PubMed] [Google Scholar]
  11. Ognibene F. P., Masur H., Rogers P., Travis W. D., Suffredini A. F., Feuerstein I., Gill V. J., Baird B. F., Carrasquillo J. A., Parrillo J. E. Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV). Ann Intern Med. 1988 Dec 1;109(11):874–879. doi: 10.7326/0003-4819-109-11-874. [DOI] [PubMed] [Google Scholar]
  12. Plata F., Dadaglio G., Chenciner N., Hoffenbach A., Wain-Hobson S., Michel F., Langlade-Demoyen P. Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination. Immunodefic Rev. 1989;1(3):227–246. [PubMed] [Google Scholar]
  13. Plata F., Dadaglio G., Chenciner N., Hoffenbach A., Wain-Hobson S., Michel F., Langlade-Demoyen P. Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination. Immunodefic Rev. 1989;1(3):227–246. [PubMed] [Google Scholar]
  14. Rose R. M., Krivine A., Pinkston P., Gillis J. M., Huang A., Hammer S. M. Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with the acquired immunodeficiency syndrome. Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):850–854. doi: 10.1164/ajrccm/143.4_Pt_1.850. [DOI] [PubMed] [Google Scholar]
  15. Salahuddin S. Z., Rose R. M., Groopman J. E., Markham P. D., Gallo R. C. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood. 1986 Jul;68(1):281–284. [PubMed] [Google Scholar]
  16. Shaw R. J., Roussak C., Forster S. M., Harris J. R., Pinching A. J., Mitchell D. M. Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis. Thorax. 1988 Jun;43(6):436–440. doi: 10.1136/thx.43.6.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Stephens J. C., Mador M. L., Cavanaugh M. L., Gradie M. I., Kidd K. K. The human genome map 1990. Science. 1990 Oct 12;250(4978):suppl–4. doi: 10.1126/science.2218516. [DOI] [PubMed] [Google Scholar]
  18. Suffredini A. F., Ognibene F. P., Lack E. E., Simmons J. T., Brenner M., Gill V. J., Lane H. C., Fauci A. S., Parrillo J. E., Masur H. Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome. Ann Intern Med. 1987 Jul;107(1):7–13. doi: 10.7326/0003-4819-107-1-7. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES